Search Results

1 - 8 of 8 items :

  • virulence genes x
Clear All
Effective anti-adhesives of uropathogenic Escherichia coli

. Furneri, Anti-adhesion activity of A2-type proanthocyanidins (a cranberry major component) on uropathogenic E. coli and P. mirabilis strains, Antibiotics (Basel) 3 (2014) 143-154; https://doi.org/10.3390/antibiotics3020143 76. M. A. Amalaradjou, A. Narayanan and K. Venkitanarayanan, Trans-cinnamaldehyde decreases attachment and invasion of uropathogenic Escherichia coli in urinary tract epithelial cells by modulating virulence gene expression, J. Urol. 185 (2011) 1526-1531; https://doi.org/10.1016/j.juro.2010.11.078 77. A. E. Stapleton, J

Open access
A preliminary report on the susceptibility to aminoglycosides of Escherichia coli isolated from the community-acquired urinary tract infections in adults in south-east Poland

References 1. Alberici I. et al.: Pathogens causing urinary tract infections in infants: A European overview by the ESCAPE study group. Eur. J. Pediatr., 2014. 2. Bien J. et al.: Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol., 2012, Article ID 681473, 2012. doi: 10.1155/2012/681473 3. Firoozeh F. et al.: Detection of virulence genes in Escherichia coli isolated from patients with cystitis and pyelonephritis. Int. J. Infect

Open access
Molecular characterization of ESBL gene in Citrobacter spp. and antibacterial activity of omega-3 against resistant isolates

.: Comparison of biochemical tests, Api system, Vitek 2 system and PCR of the enteropathogenic bacteria isolated from children with persistent diarrhea. And the occurrence of virulence factors and antibiotic resistance in the isolates. Master Thesis. Faculty of Science, University of Kufa 2014. 5. Al-Hissnawy, D.; AL-Thahab, A.A.; Al-Jubori,S.A.: Evaluation of Citrobacter freundii isolated in Najaf governorate as an enterotoxin producer. Medical J. Babylon. 9(1): 1-5, 2012. 6. Tuwaij, N.S.: Molecular Study of Quinolone Resistance in Klebsiella

Open access
Multidrug Resistance Among Enterococci at a Tertiary Care Hospital in Northern Bulgaria

References 1. Leclercq R. Enterococci acquire new kinds of resistance. Clin Infect Dis. I997;24(l):580-1. 2. Murray BE. The life and times of the Enterococcus. Gin Microbiol Rev. 1990;3:46-65. 3. Werner G, GoqucTM, Hammerum AM, Hope R, Hrynicwicz W, Johnson A, ct al Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Survcill. 2008; 3 (47)pii 19046. 4. Willems RJ, Bonten MJ. Glyoopcptidc-resistant enterococci: deciphering virulence, resistance and cpidcmicity. Cutt

Open access
Liposomal-lipopolysaccharide vaccine extracted from Proteus mirabilis induces moderate TLR4 and CD14 production

REFERENCES 1. Hegazy WAH. Diclofenac inhibits virulence of Proteus mirabilis isolated from diabetic foot ulcer. Afr J Microbiol. Res. 2016;10:733-43. 2. Schaffer JN, Pearson MM. Proteus mirabilis and urinary tract infections. J Microbiol Spect. 2015;3(5). 3. Brzozowska E, Pyra A, Pawlik K, Janik M, Górska S., Urbańska N. Hydrolytic activity determination of tail tubular Protein A of Klebsiella pneumoniae bacteriophages towards saccharide substrates. J Sci Rep. 2017;7(1):18048. 4. Brotzki CR, Mergenhagen KA,, Bulman ZP, Tsuji BT

Open access
Glycyrrhetinic acid and its derivatives in infectious diseases

, glycyrrhizin and its metabolites, J. Antimicrob. Chemother ., 54, 243, 2004. 26. Kumada H.: Long-term treatment of chronic hepatitis C with glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma, Oncology , 62, 94, 2002. 27. Lacaille-Dubois M.A., Wagner H.: A review of the biological and pharmacological activities of saponins, Phytomedicine , 2, 363, 1996. 28. Long D.R. et al.: 18β-Glycyrrhetinic Acid Inhibits Methicillin-Resistant Staphylococcus aureus Survival and Attenuates Virulence Gene Expression

Open access
Evolution of Acinetobacter baumannii infections and antimicrobial resistance. A review

genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsoniisp. nov., and Acinetobacter junii sp. nov., and emended description of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int. J. Syst. Bacteriol. 36:228-240. 5. Jones CL, Clancy M, Honnold C, et al. Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. Clin Infect Dis 2015, 61(2):145-54. 6. Choi WS, Kim SH, et al. Nosocomial Outbreak of Carbapenem

Open access
Nutrition challenges in polytrauma patients. New trends in energy expenditure measurements

References 1. Finfer S. Clinical controversies in the management of critically ill patients with severe sepsis. Virulence [Internet]. 2014;5(1):200–5. Available from: http://www.tandfonline.com/doi/abs/10.4161/viru.25855 2. Lee SH, Park MS, Park BH, Jung WJ, Lee IS, Kim SY, et al. Prognostic implications of serum lipid metabolism over time during sepsis. Biomed Res Int. 2015;2015(Ldl). 3. Simsek T, Uzelli Simsek H, Canturk NZ. Response to trauma and metabolic changes: posttraumatic metabolism. Turkish J Surg [Internet]. 2014

Open access